Mirdametinib (PD0325901) Liposomes, Formulation U6-2

Mfr.No.	DLL-0008, DLL-0008-1A-10MG, DLL-0008-1A-25MG, DLL-0008-1A-100MG, DLL-0008-1B-10MG, DLL-0008-1B-25MG, DLL-0008-1B-100MG, DLL-0008-1C-10MG, DLL-0008-1C-25MG, DLL-0008-1C-100MG, DLL-0008-1D-10MG, DLL-0008-1D-25MG, DLL-0008-1D-100MG, DLL-0008-1E-10MG, DLL-000
Alternative Names	PD0325901
Average Size	70-120 nm
Hydration Solution	292 mM sucrose, 0.5% DPBS (1X)
External Solution	U6-1
Signaling pathway	MAPK/ERK pathway
Description	PEGylated liposomes containing MEK inhibitor Mirdametinib (PD0325901). Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with an IC50 of 0.33 nM (cell-free assays). The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
Concentration	10.0 mg/mL (+- ~5%)
Concentration Total Lipid	60 mM
Cas Number	391210-10-9
Types of Liposomes	Drug Loaded Liposomes
Target	MEK

Have you used this product?

Rate it now..!!

Combination SKU	Supplier No.	Label	Volume	Your price
BHB19400004-1	DLL-0008-1A-10MG	None	1 mL	$595	Add to Cart
BHB19400004-2	DLL-0008-1A-25MG	None	2.5 mL	$995	Add to Cart
BHB19400004-3	DLL-0008-1A-100MG	None	10 mL	$2995	Add to Cart
BHB19400004-4	DLL-0008-1B-10MG	DiD	1 mL	$795	Add to Cart
BHB19400004-5	DLL-0008-1B-25MG	DiD	2.5 mL	$1195	Add to Cart
BHB19400004-6	DLL-0008-1B-100MG	DiD	10 mL	$3195	Add to Cart
BHB19400004-7	DLL-0008-1C-10MG	DiR	1 mL	$795	Add to Cart
BHB19400004-8	DLL-0008-1C-25MG	DiR	2.5 mL	$1195	Add to Cart
BHB19400004-9	DLL-0008-1C-100MG	DiR	10 mL	$3195	Add to Cart
BHB19400004-10	DLL-0008-1D-10MG	DiI	1 mL	$795	Add to Cart
BHB19400004-11	DLL-0008-1D-25MG	DiI	2.5 mL	$1195	Add to Cart
BHB19400004-12	DLL-0008-1D-100MG	DiI	10 mL	$3195	Add to Cart
BHB19400004-13	DLL-0008-1E-10MG	DiO	1 mL	$795	Add to Cart
BHB19400004-14	DLL-0008-1E-25MG	DiO	2.5 mL	$1195	Add to Cart
BHB19400004-15	DLL-0008-1E-50MG	DiO	5 mL	$3195	Add to Cart